Ventilator-associated pneumonia management in critical illness

Current Opinion in Gastroenterology

Volumn 27, Issue 2, 2011, Pages 160-166

  Albertos, Raquel ^a   Caralt, Berta ^a   Rello, Jordi ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

care bundle; enteral feeding; nutritional support; ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBON DIOXIDE; CHLORHEXIDINE; GLUCOSE; HYPERTENSIVE FACTOR; PROCALCITONIN; SEDATIVE AGENT; THIAMINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; DISINFECTION; DRUG DOSE ESCALATION; DRUG HYPERSENSITIVITY; ENDOTRACHEAL CUFF; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; ENTERIC FEEDING; FLUID BALANCE; GASTROINTESTINAL INTOLERANCE; HUMAN; HYGIENE; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LIPID METABOLISM; MALNUTRITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; NONHUMAN; NONINVASIVE VENTILATION; NUTRITIONAL SUPPORT; OROPHARYNX; PARENTERAL NUTRITION; PEPTIC ULCER; PROTEIN METABOLISM; PSEUDOMONAS AERUGINOSA; REFEEDING SYNDROME; RESPIRATORY FAILURE; REVIEW; RISK REDUCTION; SODIUM BALANCE; STOMACH PARESIS; TREATMENT DURATION; VENTILATED PATIENT; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

HUMANS; INTENSIVE CARE UNITS; NUTRITIONAL SUPPORT; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 79951673528     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32834373b1     Document Type: Review

References (49)

1. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33:2184-2193.
2. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network Facilities. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008; 36:609-626.
3. Rello J, Ollendorf DA, Oster G, et al., VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121. (Pubitemid 36051151)
4. Muscedere JG, Martin CM, Heyland DK. The impact of ventilator-associated pneumonia on the Canadian healthcare system. J Crit Care 2008; 23:5-10. (Pubitemid 351400351)
5. Zahar JR, Nguile-Makao M, Français A, et al. Predicting the risk of documented ventilator-associated pneumonia for benchmarking: construction and validation of a score. Crit Care Med 2009; 37:2545-2551.
6. Dáz LA, Llauradó M, Rello J, Restrepo MI. Nonpharmacological prevention of ventilator-associated pneumonia. Arch Bronconeumol 2010; 46:188-195.
7. Dallas J, Skrupky L, Abebe N, et al. Ventilator-associated tracheobronchitis (VAT) in a mixed surgical and medical ICU population. Chest 2010. [Epub ahead of print]
8. Torres A, Ewig S, Lode H, Carlet J, European HAP working group. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009; 35:9-29.
9. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
10. Kumar A, Safdar N, Kethireddy S, Chateau D. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta- regression study. Crit Care Med 2010; 38:1651-1664.
11. Rello J, Ulldemolins Pharmd M, Lisboa T, et al.; the EU-VAP/CAP Study Group. Determinants of choice and prescription patterns in empiric antibiotic therapy for HAP/VAP. Eur Respir J 2010. [Epub ahead of print]
12. Gaynes RP. Preserving the effectiveness of antibiotics. JAMA 2010; 303: 2293-2294.
13. Joffe AR, Muscedere J, Marshall JC, et al., Canadian Critical Care Trials Group. The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study. J Crit Care 2008; 23:82-90. (Pubitemid 351400353)
14. Sandiumenge A, Diaz E, Rodriguez A, et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother 2006; 57:1197-1204. (Pubitemid 44644425)
15. Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682. (Pubitemid 36379567)
16. Luyt CE, Guérin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171:48-53. (Pubitemid 40051694)
17. Lisboa T, Seligman R, Diaz E, et al. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008; 36:166-171.
18. Seligman R, Meisner M, Lisboa TC, et al. Decreases in procalcitonin and Creactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006; 10:R125.
19. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008; 177:498-505. (Pubitemid 351442188)
20. Ulldemolins M, Roberts JA, Wallis SC, et al. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics. J Antimicrob Chemother 2010; 65:1771-1778.
21. Rello J, Chastre J, Cornaglia G, Masterton R, on behalf of the VAP Care Bundles Contributors. A European care bundle for management of ventilatorassociated pneumonia. J Crit Care 2010. [Epub ahead of print]
22. Rello J, Lode H, Cornaglia G, Masterton R, VAP Care Bundle Contributors. A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 2010; 36:773-780.
23. Zilberberg MD, Shorr AF, Kollef MH. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med 2009; 37:305-309.
24. Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilatorassociated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29:31-40.
25. Hugonnet S, Uçkay I, Pittet D. Staffing level: a determinant of late-onset ventilator-associated pneumonia. Crit Care 2007; 11:R80.
26. Efrati S, Deutsch I, Antonelli M, et al. Ventilator-associated pneumonia: current status and future recommendations. J Clin Monitor Comput 2010; 24:161-168.
27. Kollef MH, Afessa B, Anzueto A, et al., NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 300:805-813.
28. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115. (Pubitemid 32554320)
29. Schultz MJ, Juffermans NP. Prevention of VAP: 'WHAP' should we do? Crit Care Med 2010; 38:706-707.
30. Staudinger T, Bojic A, Holzinger U, et al. Continuous lateral rotation therapy to prevent ventilator-associated pneumonia. Crit Care Med 2010; 38:486-490.
31. Panchabhai TS, Dangayach NS, Krishnan A, et al. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control. Chest 2009; 135:1150-1156.
32. Munro CL, Grap MJ, Jones DJ, et al. Chlorhexidine, toothbrushing, and preventing ventilator-associated pneumonia in critically ill adults. Am J Crit Care 2009; 18:428-437.
33. De Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360: 20-31.
34. Oostdijk EA, de Smet AM, Blok HE, et al. Ecological effects of selective decontamination on resistant Gram-negative bacterial colonization. Am J Respir Crit Care Med 2010; 181:452-457.
35. Schneider GT, Christensen N, Doerr TD. Early tracheotomy in elderly patients results in less ventilator-associated pneumonia. Otolaryngol Head Neck Surg 2009; 140:250-255.
36. Terragni PP, Antonelli M, Fumagalli R, et al. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 2010; 303:1483-1489.
37. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338:791-797. (Pubitemid 28135985)
38. Al-Tawfiq JA, Abed MS. Decreasing ventilator-associated pneumonia in adult intensive care units using the Institute for Healthcare Improvement bundle. Am J Infect Control 2010; 38:552-556.
39. Lorente L, Blot S, Rello J. New issues and controversies in the prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 2010. [Epub ahead of print]
40. Faisy C, Lerolle N, Dachraoui F, et al. Impact of energy deficit calculated by a predictive method on outcome in medical patients requiring prolonged acute mechanical ventilation. Br J Nutr 2009; 101:1079-1087.
41. McClave SA, Heyland DK. The physiologic response and associated clinical benefits from provision of early enteral nutrition. Nutr Clin Pract 2009; 24:305.
42. Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology 2001; 121:970-1001. (Pubitemid 32959408)
43. Chen YC. Critical analysis of the factors associated with enteral feeding in preventing VAP: a systematic review. J Chin Med Assoc 2009; 72:171-178.
44. Hsu CW, Sun SF, Lin SL, et al. Duodenal versus gastric feeding in medical intensive care unit patients: a prospective, randomized, clinical study. Crit Care Med 2009; 37:1866-1872.
45. Acosta-Escribano J, Fernández-Vivas M, Grau Carmona T, et al. Gastric versus transpyloric feeding in severe traumatic brain injury: a prospective, randomized trial. Intensive Care Med 2010; 36:1532-1539.
46. Montejo JC, Minambres E, Bordejé L, et al. Gastric residual volume during enteral nutrition in ICU patients: the REGANE study. Intensive Care Med 2010; 36:1386-1393.
47. Poulard F, Dimet J, Martin-Lefevre L, et al. Impact of not measuring residual gastric volume in mechanically ventilated patients receiving early enteral feeding: a prospective before-after study. JPEN J Parenter Enteral Nutr 2010; 34:125-130.
48. Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what is, and how to prevent and treat it. BMJ 2008; 336:1495-1498. (Pubitemid 351977023)
49. Gordon SD, Simpson F, Finfer S, et al. Effect of evidence-based feeding guidelines on mortality of critically ill adults: a cluster randomized controlled trial. JAMA 2008; 300:2731-2742.